Monoclonal Antibodies to Interferons

  • D. C. Burke
  • D. S. Secher
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 71)

Abstract

The introduction of a technique for the production of monoclonal antibodies by hybrid myelomas (hybridomas) (Kohler and Milstein 1975) is leading to the widespread replacement of conventional antisera by monoclonal antibodies in many areas where antibodies are used. Conventional antisera generally contain a heterogeneous population of antibodies of different affinities and recognizing a variety of different antigenic determinants. The mixture of antibodies can vary not only from animal to animal, but even in successive bleeds from a single animal and this has led to difficulties in the standardization of antisera and of substances measured by antibodies. Monoclonal antibodies are chemically pure, recognize a single determinant with a unique affinity, and can be produced over a long period of time without any change of properties.

Keywords

Sugar Carbohydrate Titration Glycol Electrophoresis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen G, Fantes KH (1980) A family of structural genes for human lymphoblastoid (leukocyte-type) interferon. Nature 287:408–411PubMedCrossRefGoogle Scholar
  2. Berg K, Ogburn CA, Paucker K, Mogenson KE, Cantell K (1975) Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. J Immunol 114:640–644PubMedGoogle Scholar
  3. Burke DC, Isaacs A (1960) Interferon: relation to heterologous interference and lack of antigenicity. Acta Virol 4:215–219Google Scholar
  4. Burrone O, Milstein C (1982) The effect of interferon on the expression of human cell-surface antigens. Proc R Soc Lond [Biol] 299:133–135CrossRefGoogle Scholar
  5. Duc-Goiran P, Galliot B, Chany C (1971) Studies on virus-induced interferons produced by the human amniotic membrane and white blood cells. Arch Virol 34:232–243CrossRefGoogle Scholar
  6. Havell EA, Berman B, Ogburn CA, Berg K, Paucker K, Vilcek J (1975) Two antigenically distinct species of human interferon. Proc Nat Acad Sci USA 72:2185–2190PubMedCrossRefGoogle Scholar
  7. Hochkeppel HK, De Ley M (1982) Monoclonal antibody against human IFN-γ. Nature 296:258–259PubMedCrossRefGoogle Scholar
  8. Hochkeppel HK, Menge U, Collins J (1981) Monoclonal antibodies against human fibroblast interferon. Nature 291:500–501PubMedCrossRefGoogle Scholar
  9. Kawade Y, Yamamoto Y, Fujisawa J, Wanatabe Y (1980) Antigenic relationship between various interferon species. Ann N.Y. Acad Sci 350:422–427PubMedCrossRefGoogle Scholar
  10. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497PubMedCrossRefGoogle Scholar
  11. Levy-Koenig RE, Golgher RR, Paucker K (1970 a) Immunology of interferons. II. Hetero-specific activities of human interferon and their neutralization by antibody. J Immunol 104:791–797PubMedGoogle Scholar
  12. Levy-Koenig RE, Mundy MJ, Paucker K (1970 b) Immunology of interferons. I. Immune response to protective and nonprotective interferons. J Immunol 104:785–790PubMedGoogle Scholar
  13. Lindenmann J (1960) Neuere Aspekte der Virus-Interferenz. Ergeb Microbiol Immunitaetsforsch 33:369–373Google Scholar
  14. Mannell D, De Maeyer E, Kemeer R, Cacherd A, De Maeyer-Guignard J (1982) A rat monoclonal antibody against mouse α and β interferon of all molecular species. Nature 296:664–665CrossRefGoogle Scholar
  15. Montagnier L, Laurent AG, Gruest J (1980) Isolement d’un hybride cellulaire produisant un anticorps specifique de l’interferon leucocytaire humain. CR Acad Sci Paris 291:893–896Google Scholar
  16. Mogensen KE, Pyhala L, Cantell K (1975) Raising antibodies to human leukocyte interferon. Acta Pathol Microbiol Scand 83:443–458Google Scholar
  17. Morser J, Meager A, Burke DC, Secher DS (1981) Production and screening of cell hybrids producing a monoclonal antibody to human interferon-α. J Gen Virol 53:257–265PubMedCrossRefGoogle Scholar
  18. Paucker K (1965) The serological specificity of interferon. J Immunol 94:371–378PubMedGoogle Scholar
  19. Paucker K, Cantell K (1962) Neutralization of interferon by specific antibody. Virology 18:145–147PubMedCrossRefGoogle Scholar
  20. Paucker K, Dalton BJ, Ogburn CA, Torma E (1975) Multiple active sites on human interferons. Proc Nat Acad Sci USA 72:4587–4591PubMedCrossRefGoogle Scholar
  21. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J (1982) Systemic lupus erthyematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 216:429–431PubMedCrossRefGoogle Scholar
  22. Saksela E, Virtanen I, Hovi T, Secher DS, Kantell K (in press) Monocyte is the main producer of human leukocyte alpha interferons following Sendai Virus Induction. Progr Med Virol 30Google Scholar
  23. Secher DS (1981) Immunoradiometric assay of human leukocyte interferon using monoclonal antibody. Nature 290:501–503PubMedCrossRefGoogle Scholar
  24. Secher DS, Burke DC (1980) A monoclonal antibody for largescale purification of human leukocyte interferon. Nature 285:446–450PubMedCrossRefGoogle Scholar
  25. Scott GM, Secher DS, Flowers D, Bate J, Cantell K, Tyrrell DAJ (1981) Toxicity of interferon. Br Med J 282:1345–1348CrossRefGoogle Scholar
  26. Staehelin T, Durrer B, Schmidt J, Takacs B, Stocker J, Miggiano V, Stahli C, Rubinstein M, Levy WP, Hershberg R, Pestka S (1981) Production of hybridomas secreting monoclonal antibodies to the human leukocyte interferons. Proc Nat Acad Sci USA 78:1848–1852PubMedCrossRefGoogle Scholar
  27. Stähli C, Staehelin T, Miggiano V, Schmidt J, Häring P (1980) High frequencies of antigen-specific hybridomas: dependence on immunisation parameters and prediction by spleen cell analysis. J Immunol Methods 32:297–304PubMedCrossRefGoogle Scholar
  28. Stewart WE II (1979) The interferon system. Springer, Wien, New YorkGoogle Scholar
  29. Stewart WE II, Havell EA (1980) Characterization of a subspecies of mouse interferon cross-reactive on human cells and antigenically related to human leukocyte interferon. Virology 101:315–318PubMedCrossRefGoogle Scholar
  30. Taniguchi T, Mantei N, Schwarzstein M, Nagata S, Maramatsu M, Weissman C (1980) Human leukocyte and fibroblast interferon are structurally related. Nature 285:547–549PubMedCrossRefGoogle Scholar
  31. Trapman J, Bosveld IJ, Vonk WP, Heckman RCAP, De Jonge P, Van Vliet PW, Van Ewijk W (1981) A monoclonal antibody to murine interferon-β. In: De Maeyer E, Galasoo G, Schellekens HJ (eds) The biology of the interferon system. Elsevier, Amsterdam, pp 77–79Google Scholar
  32. Vallbracht A, Treuner J, Flehmig B, Joester KE, Niethammer D (1981) Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon. Nature 289:496–497PubMedCrossRefGoogle Scholar
  33. Walker JR, Nagington J, Scott GM, Secher DS (1982) An immunoradiometric assay of serum interferon using a monoclonal antibody. J Gen Virol 62:181–185PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • D. C. Burke
  • D. S. Secher

There are no affiliations available

Personalised recommendations